Avidity Partners Management LP lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 47.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 58,500 shares of the healthcare conglomerate’s stock after selling 53,700 shares during the period. Avidity Partners Management LP’s holdings in UnitedHealth Group […]
Avidity Partners Management LP decreased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 24.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 570,137 shares of the company’s stock after selling 186,028 shares during the […]
Avidity Partners Management LP grew its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 55.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 844,500 shares of the biopharmaceutical company’s stock after acquiring an additional 300,500 shares during the period. […]
Avidity Partners Management LP bought a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 182,600 shares of the medical research company’s stock, valued at approximately $96,922,000. Thermo Fisher Scientific comprises […]
Avidity Partners Management LP grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 17.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,000 shares of the biopharmaceutical company’s stock after purchasing an additional 10,000 shares during the period. Regeneron Pharmaceuticals […]